Premium
P4‐349: Safety, compliance and the effects on memory of 48‐week Souvenaid use in mild Alzheimer's disease: Results from the Souvenir II and open‐label extension study
Author(s) -
Scheltens Philip,
Twisk Jos,
Blesa Rafael,
Scarpini Elio,
Arnim Christine,
Bongers Anke,
Harrison John,
Swinkels Sophie,
Wurtman Richard,
Wieggers R.L.,
Vellas Bruno,
Kamphuis Patrick
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.08.130
Subject(s) - medicine , adverse effect , clinical endpoint , disease , clinical trial